BRIEF published on 03/27/2026 at 08:20, 4 months 13 days ago Vetoquinol Reports Stable 2025 Financial Performance Amid Market Volatility Financial Performance Strategic Expansion Net Cash Position Essential Products Vetoquinol 2025
BRIEF published on 03/27/2026 at 08:20, 4 months 13 days ago Vetoquinol: 2025 Annual Results Profitability Product Mix VETOQUINOL 2025 Results Essential Products
PRESS RELEASE published on 03/27/2026 at 08:15, 4 months 13 days ago Inside Information / News release on accounts, results Vetoquinol reports 2025 annual results showing €525.7m in sales (+0.2%), highlighting growth in Essential products and improved profitability Profitability Sales Growth VETOQUINOL Essential Products 2025 Annual Results
BRIEF published on 10/28/2025 at 17:50, 9 months 11 days ago Vetoquinol Reports 9-Month Sales Decline, Despite Essential Product Growth Sales Decline Currency Impact Regional Performance VETOQUINOL Essential Products
PRESS RELEASE published on 10/28/2025 at 17:45, 9 months 11 days ago Quarterly financial reporting / Third quarter financial report Vetoquinol reports 9-month sales of €384 million, down 3.5% on a reported basis but up 0.7% excluding currency impacts and range simplification. Essential products show growth Operating Profitability Organic Growth VETOQUINOL Essential Products 9-month Sales
BRIEF published on 09/11/2025 at 17:50, 10 months 27 days ago Vetoquinol posts stable results in the first half of 2025 Treasury Half-year Results Turnover VETOQUINOL Essential Products
BRIEF published on 04/25/2025 at 10:03, 1 year 3 months ago Vetoquinol's Q1 2025 Financial Report Shows Mixed Results Market Growth Q1 2025 Financials Vetoquinol Sales Essential Products Rationalization Program
PRESS RELEASE published on 04/25/2025 at 09:58, 1 year 3 months ago Quarterly financial reporting / First quarter financial report Vetoquinol reports €85m sales for Q1 2025, with growth in Essential products sales. Strong performance outside USA, Europe up by 3%, Americas by 4%, Asia-Pacific by 25% Sales Growth VETOQUINOL Q1 2025 Essential Products
BRIEF published on 08/05/2024 at 20:03, 2 years ago Reporting on capital and voting rights - July 2024 Share Capital Voting Rights AMF Financial Transparency VETOQUINOL
Published on 08/07/2026 at 23:15, 1 day 15 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 16 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 16 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 16 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/09/2026 at 15:05, 8 minutes ago GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/09/2026 at 00:01, 15 hours 13 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 22 hours 48 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 15 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 19 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 18:54, 1 day 20 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 20 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 1 day 21 hours ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 2 days 6 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026
